Round 3 Pilot Grant RFA

Clinical and Translational Research Infrastructure Network (CTR-IN)
Funding Opportunity Announcement: Pilot Grant Program

Overview: The CTR-IN Pilot Grant Program is a Limited Competition,Mentored Career Development funding opportunity. The missionof the CTR-IN is to build clinical and translational research capacity, and facilitate extramural funding success, among investigators with faculty appointments at the 13 universities in the Mountain West Research Consortium.

The program provides research funding, and a mentored pathway of milestones leading to publication and expansion of research skills, to help faculty achieve independent investigator status as reflected in the submission of an NIH R-type grant proposal (or equivalent) in clinical or translational research.

Pilot Grant support can be transformative in the Mountain West by helping existing programs reach national competitiveness, by addressing regional health disparities, and by helping new investigators and established basic scientists achieve success in clinical or translational research.

Funding Source: National Institute of General Medical Sciences (NIGMS, U54GM104944).

Key Dates:

Final day for Submission of Nominating Packets by the institutional OSP 28 January 2015
Invitations to investigators to submit full applications will be issued by 06 February 2015
Pilot Grant Applications Due Date 08 April 2015 5:00 PM PDT
Announcement of Pilot Grant Awards 12 June 2015
Earliest Start Date 15 July 2015

Project Duration: One year (July 2015 through June 2016). No carryover beyond project period allowed.

Eligibility Requirements: Applicants must be nominated by their respective institution and subsequently invited by CTR-IN to submit a full application. Potential applicants must contact their local CTR-IN Concierge CTR-IN Concierge Network for instructions on the nominating process.
• Faculty members with at least a .5 FTE position at one of the 13 CTR-IN partner institutions are eligible to apply (see Eligible Mountain West Research Consortium Institution).
• Projects must be Clinical or Translational Research, the CTR-IN is unable to fund pre-clinical or basic science research.
• Awardees must devote at least 20% effort (2.4 person months) to the Pilot Grant project. Per IDeA program policy, an awardee may not concurrently receive research funding through other IDeA mechanisms (e.g., COBRE or INBRE).
• Only one proposal per investigator will be considered.Multi-PI projects are not allowable but co-investigators may be included.
• Early or New Stage Investigators (click here … ) are encouraged to apply.
• Established researchers intending to move from basic science into translational or clinical research are eligible to apply.
• Nominated applicants must upload a researcher profile in VIVO, the researcher network supported by CTR-IN (see CTR-IN VIVO SITE).

Funding Level and Allowable Expenses: Direct costs of up to $60,000 per year may be requested. Permitted expenses include support for half of the salary and benefits associated with the PI’s effort, salaries for research personnel, research supplies, and participant expenses. All expenses must be allowable under NIH guidelines.

The following are not allowable: Equipment costs over $5,000, significant foreign participation, and subcontracts to institutions located in non-IDeA states.

Services provided in non-IDeA states can be purchased on a fee-for-service basis.Travel expenses are allowed, if necessary,for conducting field work as part of the project, or accessing experts or other resources. Travel expenses may be requested for the PI to present this work at one national or regional meeting,providing the meeting date is far enough into the project period for data to be available.

Budgets must include costs for the PI to attend the CTR-IN Annual Meeting at Las Vegas in June 2016. For further details on allowable expenses see Budgets for allowable expenses. Applicants may request support to cover expenses of their Mentor, such as travel and consultant fees. Applicants are encouraged to work with their Office of Sponsored Projects and the CTR-IN Education,Mentoring and Career Development KCA (CREMCaD), see CREMCaD portal to ensure that their budget forms are properly completed.

Poorly completed budgets, or budgets requesting substantial support for elements that are not aligned with the CTR-IN mission to promote the PI’s development as an independent investigator, will be returned without review.

Eligible Mountain West Research Consortium Institutions:

Boise State University
Idaho State University
Montana State University
New Mexico State University
University of Alaska, Anchorage
University of Alaska, Fairbanks
University of Hawaii
University of Idaho
University of Montana
University of New Mexico
University of Nevada Las Vegas
University of Nevada Reno
University of Wyoming

APPLICATION PROCESS: Applicants are strongly encouraged to visit the CTR-IN website for further details and answers to Frequently Asked Questions (see Frequently Asked Questions).

Limited competition nomination of applicants from eligible institutions: Interested applicants must coordinate with their respective institution’s Research Office and CTR-IN Concierge (see CTR-IN Concierge Network). Each institution may nominate up to four applicants. Nominating Packets must be submitted by the institution’s Office of Sponsored Programs. Submission will be electronic through the CTR-IN Pilot Grant Application Portal at: Pilot Grant Evaluation Interface and initial packets must be received by 5:00 PM PST on January 28, 2015. Nominating Packets must include the following for each applicant:

• An NIH format Biographical Sketch for the proposed PI including the required Personal Statement. See (http://grants.nih.gov/grants/funding/2590/biosketchsample.pdf)
• An NIH format Other Support document for the proposed PI. See http://grants.nih.gov/grants/funding/2590/Non-competing_othersupport.pdf
• A summary of the proposed research of not more than one page with sufficient detail to establish that the research is clinical or translational.
• A summary of the IRB status (IRB proposal in preparation, submitted, or approved with a copy of the approval). If IRB approval is not required, the reason must be documented.
• A letter of support signed by an appropriate institutional official committing to provide support for half of the requested PI effort if the CTR-IN Pilot Grant is awarded.
• Identification of the project mentor, and a letter of support from the proposed mentor indicating willingness to work with the prospective PI. For assistance in identifying a mentor, see (Mentoring)

Invitation to submit pilot grant application: Nominating Packets will undergo administrative review to ensure that they are responsive to this announcement. Administrative reviews will be conducted on a rolling basis within 7 business days of submission. OSP representatives will be notified of any rejections. A Nominating Packet that is rejected as non-responsive to this RFA may be replaced with another while the Nomination phase is open through 5:00 PM PST on January 28, 2015. Early submission of Nominating Packets is encouraged in order to allow adequate time to prepare a replacement for any that are rejected. Applicants with approved Nominating Packets will be invited to submit a full application.

Full application: Invited applicants will submit materials electronically through the CTR-IN Pilot Grant Application Portal in collaboration with their Office of Sponsored Programs. The portal is located at: Pilot Grant Evaluation Interface Applications must use the PHS 398 forms (where indicated). Instructions on the use of those forms are available at: http://grants.nih.gov/grants/funding/phs398/phs398.html. Applications must conform to standard NIH formatting requirements with regard to fonts, size and margins (e.g., Arial, 11 point, ½” margins).The following items should be included in your submission:

1. Face Page (Form Page 1). http://grants.nih.gov/grants/funding/phs398/phs398.html

2. Checklist with F&A cost breakdown at 10% http://grants.nih.gov/grants/funding/phs398/phs398.html (Checklist Form Page)

3. Project Summary and Relevance, Listing of Key Personnel, and Project/Performance Site (Form Page 2).http://grants.nih.gov/grants/funding/phs398/phs398.html

4. Detailed Budget (Form Page 4). Note: Facilities and Administration Costs are limited to 10%. http://grants.nih.gov/grants/funding/phs398/phs398.html
Special requirements regarding PI support: Pilot Grant Principal Investigators must devote at least 20% effort to the proposed research; up to 50% effort may be proposed. While the budget narrative must reference the full amount of effort required to accomplish the proposed scope of work, the budget may request CTR-IN funds for not more than half of the PI effort. The balance of PI effort is to be covered by institutional support in the form of release from teaching, direct salary support, assignment of time provided to pursue scholarly activity, or other mechanism appropriate to the institution. This support is not formal cost share and no recording/reporting requirements exist. Budgets should list the full PI effort proposed as appropriate for their appointment in calendar months, or academic and summer months. Support requested may not exceed half of that value.

5. NIH format Biographical Sketch for Key Personnel only (four page maximum per individual).

6. Detailed budget justification. For additional guidance on budget and allowable expenses please see FAQs.

7. Introduction—for resubmissions only. Prior, unfunded applicants are encouraged to include an Introduction page to address prior external reviewer comments and to indicate specific changes that have been made to the application in response to reviewer comments(not to exceed 1 page).

8. Progress Report—for current Pilot Grant awardees only. Current CTR-IN Pilot Grant awardees applying for competitive renewal must include a one-page progress report describing the achievements to-date of their current project.

9. Specific Aims (not to exceed one page).

10. Research Strategy (not to exceed four pages). Research Strategy should include:
10.1. Significance
10.2. Innovation
10.3. Approach. Note—in addition to research methods, the approach section should include the following:
10.3.1. Project timeline
10.3.2. Interim milestones
10.3.3. Plans for future extramural grant application

11. Literature Cited (no page limit).

12. Targeted/Planned Enrollment Table (if applicable) must use this form: http://grants.nih.gov/grants/funding/phs398/CumulativeInclusionEnrollmentReport.pdf

13. Protection of Human Subjects section (no page limit) must use this form: http://grants.nih.gov/grants/funding/424/SupplementalInstructions.pdf#Part_II

14. Mentor Support: Up to $2,000 may be budgeted to covermentor consultant feesand mentor travel costs. This item should be listed in the detailed budget as a separate line item. It will not count against the $60,000 research budget limit. It should, however, be added to your total Direct Costs. Contact your Office of Sponsored Projects to assist with your budget.

15. Fully executed Memorandum of Agreement between PI and Mentor (see Mentoring). For questions regarding the MOA, please contact Bruce Shiramizu at bshirami@hawaii.edu

Special Note Regarding Human Subjects Research: IRB approval letter (or IRB exemption letter) and documentation of human subjects training for key personnel (e.g., CITI) must be available upon request during the Just In Time phase (May 15, 2015 – June 30, 2015). Projects without IRB approval as of July 1, 2015 may be passed over.

CTR-IN Resources to Assist Applicants:
• Frequently Asked Questions (FAQs) about the Pilot Grant Program can be found at: Frequently Asked Questions.
• Each participating institution has a biostatistician supported by CTR-IN to assist prospective investigators in developing their research ideas. This biostatistical support is provided free of charge. Participation of the CTR-IN biostatistician in the drafting of proposals, and as the biostatistical co-investigator, is mandatory (see CTR-IN Biostat Support Contacts).
• The CTR-IN provides mentorship and educational support to assist researchers at partner institutions (see Mentoring).
• The CTR-IN currently funds pilot award investigators at each of the Mountain West institutions. A list of current awardees and their projects can be found at: Pilot Grants Awarded.
• Any questions about the Pilot Grant Program can be directed to Curtis Noonan (curtis.noonan@umontana.edu) and William Shuttleworth (bshuttleworth@salud.unm.edu).

To download the Word document version of this FOA, Click here …

Gwen Marchand Bio

Gwen Marchand, PhD, will serve as the Director for the new upcoming Tracking & Evaluation (T&E) Core in Years 6-10 of the MW CTR-IN Program. She is currently the Director of the University of Nevada, Las Vegas Center for Research, Evaluation, and Assessment (CREA) and oversees the evaluation training and coursework of graduate students. She is also an Associate Professor in the Department of Educational Psychology and Higher Education. Dr. Marchand received her Masters and PhD degrees in Psychology from Portland State University, Portland, Oregon.

During her doctoral degree, she focused on rural and urban disparities in access to health care and youth risk behaviors in Oregon. More recently, she collaborated on a proposed project to investigate future thinking and health behaviors in minority youth and has conducted research and evaluation in diverse areas, including but not limited to team science in biomedical research fields, community health, drug court/treatment partnerships, built environments, statewide technology use, and STEM curriculum implementation. Dr. Marchand’s expertise is in assessment and evaluation methodologies that include methods for assisting with program development, formative assessment practices for program improvement, and summative assessment to demonstrate impact. Her evaluation work is grounded in a pragmatic approach that is theory-driven and emphasizes the generation of information that is useful to program stakeholders, funders, and policy-makers. As a trained systems scientist and psychologist, she has a strong quantitative tradition that has grown to include mixed-methods including expertise in measurement and assessment strategies and development, advanced statistics and the use of explanatory mixed-methods.

Robert Seville Bio

Robert “Scott” Seville, PhD, will serve as the Associate Director of the MW CTR-IN Pilot Projects Core. He is currently a Professor of Zoology and Physiology in the College of Arts and Sciences at the University of Wyoming. Currently, he serves as the Lead Concierge for MW CTR-IN Concierge Network. Previously, he served as the Associate Dean for the University of Wyoming Outreach School where he had oversight of UW facilities, staff and programs across Wyoming including managing UW Academic Regional Centers located on each Wyoming community college and the Wind River Indian Reservation. He received his Master’s and PhD degrees, and Postdoctoral training in Zoology/Physiology/Parasitology from the University of Wyoming, Laramie, in Wyoming followed by a NSF/NATO Fellowship in Parasitology.

Dr. Seville’s research has focused on the taxonomy, systematics, and parasite-host co-evolution using gastrointestinal protozoan parasites (coccidia) in wild hosts as a model system. Additionally, he brings experience in leading and managing NIH-funded activities as the Program Director/Principal Investigator, Outreach/Education Core Director, and previously Program Coordinator for the IDeA-funded Wyoming INBRE program. In these leadership roles, he has been responsible for working with the INBRE leadership team and the University of Wyoming Office of Research and Economic Development in managing ~$35M in support from NIGMS IDeA Programs with a number of research, education programs and projects focused on addressing health disparities in rural and American Indian communities in Wyoming.

Tony Ward Bio

Tony Ward, PhD, will serve as the Director for the new upcoming Community Engagement and Outreach (CEO) Core in Years 6-10 of the MW CTR-IN Program. In addition to teaching within University of Montana’s School of Public and Community Health Sciences, Dr. Ward’s research focuses on investigating the relationship between air pollution and respiratory health, working with rural and American Indian (AI) and Alaska Native (AN) populations throughout our region. Concurrently, he is the Co-PI on two NIEHS-funded R01s investigating the impact of residential wood burning on respiratory health in both children and elderly populations living in rural and tribal areas located in the southwest, northern Rocky Mountains, and rural Alaska Native communities. He is also the Co-PI on a NIH funded Science Education Partnership Award (SEPA) project that educates rural and AI/AN students in schools throughout Montana, Idaho, and Alaska about air quality/respiratory health. Moreover, Dr. Ward is the Chair at the University of Montana, School of Public and Community Health Sciences in Missoula, Montana, and the State of Montana Director of the CEO Core for the AI/AN Clinical Translational Research Project (CTRP). Dr. Ward received his Masters degree in Environmental Science and Industrial Hygiene from the University of Houston, Clear Lake in Texas, and his PhD degree in Environmental Chemistry from the University of Montana, Missoula, in Montana along with a Postdoctoral.

Dr. Ward has experience conducting Community Based Participatory Research (CBPR) in rural and underserved communities, including AI/AN communities. His experience with the AI/AN CTRP will be a valuable asset for his role as the CEO Core Director for the CTR-IN, providing synergy for both of the IDeA Programs.

Fares Qeadan Bio

Fares Qeadan, PhD, is the Associate Director for the MW CTR-IN BERD Core. Dr. Qeadan is also an Assistant Professor of Biostatistics in the Department of Internal Medicine at the University of New Mexico (UNM) HSC. He also teaches the biostatistics courses for the Biomedical Sciences Graduate Program (BSGP) and participates in team science as a biostatistician with the UNM HSC Clinical & Translational Science Center (CTSC). He holds two Master’s degrees in Mathematics and Statistics from the University of Nevada, Reno in Nevada and Michigan State University, East-Lansing in Michigan.

Dr. Qeadan has over 10 years of experience in the field of Biostatistics and Computer Science including extensive experience in statistical design and analysis in the areas of public health/epidemiology and biostatistics centers. Moreover, he brings experience from his work at the Nevada State Health Division and work on projects for the Sandia National Labs. His research interests extend to the areas of linear models (mixed effect models), generalized linear models (logistic/Poisson regression), distribution theory (boundary cases), extreme value theory (peak over threshold), time-series with regressors, Bayesian methods for hierarchical models, and Big Data including EMR such as the Cerner Health Facts database, Medicaid, and HIS General Data Mart. Dr. Qeadan has authored a diverse body of work regarding health disparities in which he has examined wide array of topics including the Hispanic Epidemiological Paradox and health outcomes in dynamic populations. His work on health disparities involved and touched other relevant areas of research including the developing of statistical methods for neurology, immunology, microenvironment data with emphasis on cytokines and chemokines. These methods are applied on data to statistically demonstrate differentials in the immune response profiles between males and females, and different race and ethnicity groups which in turn contributes to implementing better measures and promising interventions to reduce health disparities.

Cristiana Iosef Bio

Cristiana Iosef, PhD, is the Associate Director of the Professional Development Core (PDC) for the MW CTR-IN Program. In this role, she coordinates the Advance to Funding (ATF) Program and the Grant Writing Workshops (GWW). She received her PhD degree in Immunology/Microbiology from the University of Timisoara / WUSTL School of Medicine in St. Louis, Missouri. She received her Postdoctoral training in Immunology/Virology from the Ohio State University, Wooster in Ohio, and additional Postdoctoral training in Medical Biochemistry from the University of Western Ontario in Ontario, Canada. Dr. Iosef is also an Associate Professor of Pharmacology at the University of Nevada Reno.

In this role for the ATF Program, she assists research investigators in the review of their grants prior to submission to the NIH to provide constructive feedback from our many expert reviewers to increase their probability of extramural funding. Hence, the ATF Program functions very much like a “study section”. She is also in charge of coordinating the GWWs, which assist research investigators in improving their knowledge and skills in the preparation of grants to make them more competitive for extramural grant funding. Additionally, she has extensive experience in medical research and education, including studies of health disparities associated with abnormal child development and perinatal pathologies governed by growth factor(s) deficiencies such as in a state of malnutrition.

Merle Kataoka-Yahiro Bio

Merle Kataoka-Yahiro, DrPH, MS, APRN is an Associate Director of the Professional Development Core of the MW CTR-IN Program since 2013. She coordinates the Education/Training for the PDC. She is a Professor in the School of Nursing and Dental Hygiene at the University of Hawaii at Manoa. Additionally, she has served as PI for the NIH Extramural Associates Research Development (EARDA) Awards, Office of Research Development in 2013, and served as the Section Leader and Co-Leader for the Research Centers in Minority Institutions (RCMI) Multidisciplinary and Translational Research Infrastructure Expansion Hawaii Grant (RMATRIX) from 2010 – 2014. Dr. Kataoka-Yahiro earned two Master’s degrees in Parent-Child Nursing (Rush University) and Public Health (Northwestern University) and a DrPH in Public Health from the University of Illinois, School of Public Health in Chicago, Illinois.

Dr. Kataoka-Yahiro’s research area has been in health disparities research focused on chronic disease management with vulnerable populations which include women, children, older adults, and minority populations. Currently, she is examining and analyzing population data sets of Asian Pacific Islander and Native Hawaiian groups and chronic diseases, specifically in prevention of chronic kidney disease (CKD) and associated cardiovascular risk factors (diabetes, hypertension, and obesity). Dr. Kataoka-Yahiro has mentored a cadre of diverse faculty and students through developing and providing scientific research training opportunities targeting towards health disparities research in clinical translational research.

Yiliang Zhu Bio

Yiliang Zhu, PhD, is the Director of the Biostatistics, Epidemiology and Research Design (BERD) core for the MW-CTR-IN Program. He is also a Professor in the Division of Epidemiology and Biostatistics in the Department of Internal Medicine at the College of Medicine at the University of New Mexico HSC. He received his Masters and PhD degree in Statistics from Queen’s University, Kingston and University of Toronto, Toronto, Canada.

Dr. Zhu’s expertise is in data analytics. His recent research has focused on health system and policy, health outcome evaluation, and data analytic methods. In the Loess Plateau Health Project (2013-2030) in northwestern rural China, he established a multidisciplinary, international team during his Fulbright Fellowship (2012-13) during which he and his team conducted observational and interventional studies on healthcare system development, policy assessment, health promotion, as well as health disparities within the content of the local environment and rural development. Additionally, he has actively conducted research in statistics methods, focusing on spatially and temporally clustered data and applications in health risk assessment. More recently, he has studied integrative system modeling as informed by biological mechanisms to seek ways to integrate data across heterogeneous systems. He has over 20 years of collaborative experiences in health and clinical and translational research, as well as experience in leading biostatistics research support in academic settings. He is committed to integrating biostatistics support into the fabric of MW CTR-IN clinical and translational research culture.

C. William Shuttleworth Bio

C. William “Bill” Shuttleworth, PhD, is the Core Director of the Professional Development Core (PDC) for the MW CTR-IN Program. He received dual B.Sc. degrees (with honors) in Pharmacology/Biochemistry and Anatomy from Adelaide University and Flinders University of South Australia and a PhD degree in Physiology from the University of Melbourne, Victoria in Australia. He also completed his Postdoctoral training in Physiology from the University of Nevada, Reno in Nevada.

Dr. Shuttleworth has been involved in leadership roles for the MW CTR-IN Program since its inception, having initially served as the Associate Director of the Pilot Projects Program In 2016, Dr. Shuttleworth transitioned to a leadership role for PDC [formally termed Clinical Research Education, Mentoring and Career Development (CREMCaD) in the initial funding phase]. In addition, Dr. Shuttleworth serves as the Associate Director of the University of New Mexico (UNM) Health Science Center’s (HSC) Clinical and Translational Research Center (CTSC), and has worked with a large number of UNM clinical and translational investigators to help develop new projects, programs and their careers in clinical and translational research. Moreover, he currently directs the CTSC’s Research Expertise and Methods, which includes training and career development activities that further supplements his leadership role of the CTR-IN PDC.

Dr. Shuttleworth’s research has a strong clinical and translational focus. He is the Principal Investigator of the Center for Brain Recovery and Repair, which is funded through a COBRE mechanism by the National Institute of General Medical Sciences (NIGMS). His research is developing clinical interventions for underserved patients in New Mexico who have experienced brain injuries.

Eric Prossnitz Bio

Eric Prossnitz, PhD, is the Associate Director of the Professional Development Core for the MW CTR-IN Program. As the Associate Director for the PDC, Dr. Prossnitz’s focus is on the Mentorship Program. Dr. Prossnitz is also currently the Co-Director of the Translational Cancer Biology and Signaling Program at the UNM HSC Comprehensive Cancer Center, the Team Science lead within the UNM HSC Clinical and Translational Science Center (CTSA), the UNM HSC institutional PI of the NM-INBRE, and the Associate Director for the UNM COBRE in Autophagy, Inflammation and Metabolism. Dr. Prossnitz received his B.Sc. degree (with honors) from the University of Victoria in Canada and a PhD in Biochemistry from the University of California, Berkeley in California. He received his postdoctoral in Immunology from Scripps Clinic and Research Foundation.
Additionally, Dr. Prossnitz developed a Biodesign program at UNM HSC that brings together faculty from the School of Engineering and the Health Sciences Center to innovate clinical technologies. He has mentored large numbers of research investigators to develop new projects and programs that has facilitated their careers in clinical and translational research. His mentoring experience over the last 20 years provides a strong basis for his leadership for the Mentorship Program within the CTR-IN PDC.

Curtis Noonan Bio

Curtis Noonan, MA, PhD, is the Director of the MW CTR-IN Pilot Projects Program. He has served in this role for the past five years and will continue to serve in this role for the next grant cycle. The Pilot Projects Program has successfully administered the single institution, single investigator and the multi-site pilot grants since the inception of the MW CTR-IN Program.

Dr. Noonan received his MA degree in International Health and Development from George Washington University and his PhD in Environmental Health, Epidemiology from Colorado State University. He is currently a Professor of Epidemiology in the College of Health Professions and Biomedical Sciences at the University of Montana. He has led NIH funded multi-site randomized trials focused on improving health outcomes and reducing exposures among vulnerable populations exposed to elevated levels of particulate matter from burning of biomass fuels for residential heating. Dr. Noon is a member of the Infectious, Reproductive, Asthma and Pulmonary Conditions (IRAP) Study Section.

Carl Reiber Bio

Carl Reiber, PhD, has served as the MW CTR-IN Program Deputy Director since 2013. He is also the Senior Vice Provost and a Professor in the School of Life Sciences at the University of Nevada, Las Vegas in the College of Sciences. Additionally, he has been the Program Coordinator of the NV INBRE since 2008, and the Steering Committee Lead since 2017. Previously, he was the cluster leader in two statewide NSF EPSCoR grants ($6M) and functioned as the coordinator for an NIH Bridges grant. He also served as an ad hoc and permanent member of several NSF review panels including mentoring numerous undergraduate and graduate students (MS and PhD). Dr. Reiber received his Masters degree in Cell Biology from George Mason University, Fairfax in Virginia and PhD degree in Zoology-Physiology from the University of Massachusetts in Amherst Massachusetts followed by Postdoctoral training from the University of Florida, Gainesville, Florida.

Richard Larson Bio

Richard Larson, MD, PhD, serves as the CTSC Liaison for the MW CTR-IN Program. He is the Executive Vice Chancellor for Research of Health Sciences at the University of New Mexico Health Sciences Center as well as a tenured Professor at the University of New Mexico. In addition, he is also the PI of the UNM Clinical and Translational Science Center. He also served on the Board of Directors for the National Center for Genome Research. In 2001, he co-founded Cancer Services of New Mexico, a non-profit organization which serves, free of charge, over 2000 New Mexicans suffering from cancer each year. Moreover, he is the President of the Cancer Services of New Mexico Foundation. In addition, Moreover, he also serves as the Chair of the Mountain West Research Consortium, which was critical in laying down the ground work for the eventual development of the MW CTR-IN Program. Dr. Larson received his MD and PhD degrees from Harvard University and performed his residency training at Washington University in St. Louis and fellowship training at Vanderbilt University in Pathology.

Parvesh Kumar Bio

Parvesh Kumar, MD, is the Principal Investigator (PI) of the MW CTR-IN Program. In addition, he also, serves as the Vice Dean of Research for the UNLV School of Medicine. Dr. Kumar received his B.Sc. degree (with honors) in Chemical Engineering from the University of Kansas in 1981 and his M.D. degree from the University of Kansas School of Medicine in 1986. He completed his residency training in Radiation Oncology at Thomas Jefferson University Hospital in 1990, while also serving as Chief Resident and Fellow of the American Cancer Society during his senior year.

Dr. Kumar is an experienced clinical and translational researcher who has led several multi-institutional, multi-disciplinary national oncology clinical trials sponsored by the NCI [i.e., Cancer & Leukemia Group B (CALGB) Protocols 8935 and 9134 in Non-Small Cell Lung Cancer and CALGB Protocol 9493 in Prostate Cancer, and Radiation Therapy Oncology Group Protocol Protocol 9615 in Head & Neck Cancer]. In addition, he has also conducted several other federal (i.e., Department of Defense) and pharma (i.e., Aventis Oncology) funded investigator initiated clinical trials. Moreover, his leadership experiences include building and managing research programs as Chair of the Departments of Radiation Oncology at 4 major medical schools and at several NCI-designated Cancer Centers. In his several research leadership roles, he has developed significant experience in health disparity research. For example, as Associate Director of Clinical Research for the University of Kansas Cancer Center, ensuring appropriate enrollment of under represented patient populations to therapeutic clinical trials was a critical requirement for the NCI and an important objective of his leadership role.

Xiaomeng (Mona) Xu

Dr. Xu is a 2015 MW CTR-IN Pilot Grant Awardee recipient. Her project was entitled, “Understanding the Role of Self-Expansion in Physical Activity”. Her research focuses on cardiovascular behavioral health including weight control, smoking and physical activity; close relationships, especially romantic; and magnetic resonance imaging (MRI) neuroimaging. Dr. Xu is also interested in these research areas in the context of individual differences such as trait self-control, and development over time, such as aging or as a romantic relationship progresses.

Dr. Xu received a Bachelor of Arts Degree in psychology from New York University, and Master of Arts Degree in psychology from Stony Brook University, and a Ph.D. in social health psychology from Stony Brook University. She completed a postdoctoral research fellowship sponsored by the National Institutes of Health at The Warren Alpert Medical School of Brown University and The Miriam Hospital.

Dr. Xu is an Assistant Professor of Experimental Psychology at Idaho State University and was honored as a 2015 Rising Star from the Association for Psychological Science. As a result of her advanced work in the field, the Association for Psychological Science has recognized Dr. Xu as an outstanding psychological scientist. As facilitated by the Individualized Development Plan (IDP) which is a critical component of the CTR-IN PG award, Dr. Xu had a successful mentorship experience with her mentor, Claudio Nigg, PhD, from the University of Hawaii. The pilot grant’s IDP provides mentorship for career development. As a result of the mentoring facilitated by the IDP, Dr. Xu has collaborated with Dr. Nigg on various projects, which have led to a manuscript publication, poster presentations, future collaborations, etc. Moreover, based on her academic productivity which has been significantly facilitated by the MW CTR-IN PG award, she will be applying for tenure at Idaho State University.

Susan Tavernier

Education: BSN from Whitworth University in Spokane in Washington; MSN from Loyola University of Chicago; PhD in Nursing from the University of Utah; Postdoctoral fellowship from the College of Nursing at the University of Utah.

MW CTR-IN helped to provide education in grant management, post-award processes, timeline projections, and meaningful tools for grant tracking.

Dr. Tavernier was a Year 4 MW CTR-IN Pilot Grant Awardee in 2016. Her project was entitled, “The Patient Voice in Healthcare”. The MW CTR-IN pilot grant was also instrumental in helping her with the nuances of grant management including hiring personnel, budgets, quarterly and annual reports. As a nurse scientist, her research area focuses on cancer patients. She has gained expertise with large qualitative data sets and has conducted research in the clinical setting. Dr. Tavernier is currently an Assistant Professor at Idaho State University in the School of Nursing and was a recipient of a Presidential Scholarship for new health service researchers from Academy Health.
Additionally, she has authored a chapter on Symptom Distress in the textbook Cancer Symptom Management 4th Edition, and has served as a review panel member for the Oncology Nursing Foundation for research and awards. She is also an active member of the Oncology Nursing Society.

Blakely Brown

Education: PhD in Nutritional Biochemistry from the University of Minnesota; RD from the University of Minnesota

MW CTR-IN helped to expand collaborations for a nutrition and physical activity study with a direct impact on the health of community children.

Dr. Blakely Brown was a MW CTR-IN Pilot Grant (PG) Awardee and Visiting Scholar in 2014. Her project was entitled, “Developing and Pilot Testing Parent Education Activities within a Childhood Obesity Prevention After-School Program”. Dr. Brown built upon this PG research funding from the MW CTR-IN Program and secured 3 additional extramural grants also in the areas of childhood obesity totaling $278,167 in extramural grant funding as follows: (1) Partnerships to Prevent Childhood Obesity on the Flathead Indian Reservation; (2) Generations Health Project: An After-School and Home Based Childhood Obesity Prevention Program; (3) and USDA Strengthening Grant: Growing Strong Generations. These research studies have allowed Dr. Brown to successfully expand her research collaborations with rural and Native American communities that have resulted in longitudinal outcomes reporting risk factors for diabetes in native and non-native children, assessments of environmental and behavioral factors associated with risk for childhood obesity and diabetes in youth in rural communities.
Dr. Brown’s research, teaching and service focus on nutrition and chronic disease prevention, maternal-child health, childhood obesity and diabetes prevention, community-based participatory research methods, Native American health and diversity-related activities.

film izle kuşadası escort antalya escort antalya escort agario unblocked agario film izle dizi izle film izle agario a href="http://www.onlinemacizletv.com/" title="mac izle">mac izle film izle Başakşehir elektrikçi